Research Updates: parkinson's disease

Below are short extracts from research updates about this subject - select more to read each item.

  1. Issue 293

    LA COGNATA  and COLLEAGUES, 1 Section of Human Anatomy and Histology, Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy; 2 Institute of Neurological Sciences, National Research Council, Catania, Italy1


  2. Issue 270

    MAIDAN and COLLEAGUES, 1. From the Center for the Study of Movement, Cognition, and Mobility, Neurological Institute (I.M., K.R.-K., Y.J., N.G., J.M.H., A.M.), and Laboratory of Early Markers of Neurodegeneration (A.M.), Tel Aviv Souras1


  3. Issue 265

    KWOK and COLLEAGUES, 1. The Nethersole School of Nursing, Faculty of Medicine, The Chinese University of Hong Kong, 6/F. Esther Lee Building, Shatin, Hong Kong, Special Administrative Region of China. jojo.yykw1


  4. Issue 252

    AROXA and COLLEAGUES, 1. Academic of Medicine graduation of Federal University of Pernambuco - Recife, Pernambuco (PE), Brazil; 2. Pro-Parkinson Program of Clinical Hospital of Federal University of Pernambuco - Recife (PE), Brazil; 3. Clinical Medi1


  5. Issue 228

    LIU and COLLEAGUES, (1)The Laboratory of Food and Biodynamics, Graduate School of Bioagricultural Science, Nagoya University, Nagoya, 464-8601, Japan, explored the possibility that r1


  6. Issue 225

    WANG and COLLEAGUES,  (1)The Center of Neurology and Rehabilitation, Second Affiliated Hospital of Wenzhou Medical College, 109 Xueyuan West Road, Wenzhou, Zhejiang 325027, China set out to determine the epidemiology of CAM use for Parkinson's 1


  7. Issue 223

    MUROYAMA, Laboratory of Alternative Medicine and Experimental Therapeutics, Department of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Hokuriku University, Ho-3  Kanagawa-machi, Kanazawa 920-1181, Japan.


  8. Issue 206

    MIYAKE and COLLEAGUES,  Parkinson's Disease Study Group, Department of Public Health, Faculty of Medicine, Fukuoka University, Fukuoka Department of Public Health, Osaka, Japan.


  9. Issue 193

    TANAKA and COLLEAGUES, Department of Public Health, Faculty of Medicine, Fukuoka University, Fukuoka 814-0180, Japan. assessed the association between caffeine and risk of Parkin1


  10. Issue 184

    BENKLER and COLLEAGUES,  Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel review [51 refs] and describes the immune alterations and components observed in Parkinson's disease (PD) patients.


  11. Issue 180

    SCHLESINGER and COLLEAGUES, Department of Neurology, Rambam Health Care Campus, Haifa, Israel.  set out to determine whether Parkinson's Disease (PD) tremor improv1


  12. Issue 172

    CHAE and COLLEAGUES, Department of Meridian and Acupoint, College of Korean Medicine, Kyung Hee University, Dongdaemun-gu, Seoul, Republic of Korea explored the effects of acupuncture treatment upon motor function in patients with Parkinson's disease (1


  13. Issue 169

    CHEN and COLLEAGUES, Department of Neurology, Chang Gung Memorial Hospital, Chang-Gung University College of Medicine, Taipei, Taiwan.  investigated the relationships between oxida1


  14. Issue 160

    LAM and COLLEAGUES, School of Chinese Medicine, Hong Kong Baptist University, Kowloon Tong, Hong Kong assessed and reviewed the safety and clinical efficacy of acupuncture therapy in patients with idiopathic Parkinson's disease (IPD).


  15. Issue 146

    TAMIR and co-authors, Department of Physical Therapy, Sapir Center, Meir General Hospital, Kfar Saba, Israel,, have assessed the novel treatment of motor imagery practice 1


  16. Issue 145

    KANG and co-workers, Department of Meridian and Acupoints, College of Korean Medicine, Kyung Hee University, Seoul, South Korea; WHO Collaborating Centre for Traditional Medicine, East-West Medical Research Institute, Kyung Hee University, Seoul, South1


  17. Issue 123

    ETMINAN and co-authors, Division of Clinical Epidemiology, Royal Victoria Hospital and McGill University, Montreal, Quebec, Canada,, have meta-analyzed studies on antioxidant vitamins and Parkinson's disease.


  18. Issue 117

    ETMINAN and colleagues, Division of Clinical Epidemiology, Royal Victoria Hospital and McGill University, Montreal, Quebec, Canada,, have analyzed the relationship between antioxidant vitamin intakes and the risk o1


« Prev Next »

ICAN 2024 Skyscraper

Scientific and Medical Network 2

Cycle Around the World for Charity 2023

Climb Mount Kilimanjaro Charity 2023

top of the page